{"nctId":"NCT00960141","briefTitle":"A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)","startDateStruct":{"date":"2000-08"},"conditions":["Seasonal Allergic Rhinitis"],"count":829,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: montelukast sodium"]},{"label":"2","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Comparator: loratadine"]},{"label":"3","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Comparator: placebo"]}],"interventions":[{"name":"montelukast sodium","otherNames":[]},{"name":"Comparator: loratadine","otherNames":[]},{"name":"Comparator: placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has a documented clinical history of seasonal allergic rhinitis symptoms that become worse during the study season\n* Patient is a non-smoker\n* Patient is in good mental and physical health\n\nExclusion Criteria:\n\n* Patient is hospitalized\n* Patient is a woman who is \\<8 weeks postpartum or is breast feeding\n* Patient intends to move or vacation away during the study\n* Patient is a current or past abuser of alcohol or illicit drugs","healthyVolunteers":false,"sex":"ALL","minimumAge":"15 Years","maximumAge":"85 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Mean Change From Baseline in Daytime Nasal Symptoms Score","description":"Mean change from baseline in Daytime Nasal Symptoms score on a 4-point scale \\[0(best) to 3(worst)\\]. The average of the 4 individual nasal symptoms scores (Congestion, Rhinorrhea, Itching, and Sneezing) was reported as the Daytime Nasal Symptoms Score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.32","spread":null},{"groupId":"OG001","value":"-0.38","spread":null},{"groupId":"OG002","value":"-0.47","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Nighttime Symptoms Score","description":"Mean change from baseline in Nighttime Symptoms Score on a 4-point scale \\[0(best) to 3(worst)\\]. The average of 3 scores (Nasal Congestion Upon Awakening, Difficulty Going to Sleep, and Nighttime Awakenings) was reported as the Nighttime Symptoms Score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.18","spread":null},{"groupId":"OG001","value":"-0.28","spread":null},{"groupId":"OG002","value":"-0.26","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Daytime Eye Symptoms Score","description":"Mean change from baseline in Daytime Eye Symptoms scores on a 4-point scale \\[0(best) to 3(worst)\\]. The average of the 4 individual eye symptoms scores (tearing, itchy, red, and puffy eyes) was reported as the Daytime Eye Symptoms Score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.23","spread":null},{"groupId":"OG001","value":"-0.29","spread":null},{"groupId":"OG002","value":"-0.35","spread":null}]}]}]},{"type":"SECONDARY","title":"Patient's Global Evaluation of Allergic Rhinitis","description":"An evaluation by the patient, administered at the last visit (or upon discontinuation) using a 7-point scale, in answer to a single question regarding the change in symptoms as compared to the beginning of the study. Responses were assigned numerical values from 0 (very much better) to 6 (very much worse).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.62","spread":null},{"groupId":"OG001","value":"2.43","spread":null},{"groupId":"OG002","value":"2.27","spread":null}]}]}]},{"type":"SECONDARY","title":"Physician's Global Evaluation of Allergic Rhinitis","description":"An evaluation by the physician, administered at the last visit (or upon discontinuation) using a 7-point scale, of the change in symptoms as compared to the beginning of the study. Responses were assigned numerical values from 0 (very much better) to 6 (very much worse).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.53","spread":null},{"groupId":"OG001","value":"2.35","spread":null},{"groupId":"OG002","value":"2.26","spread":null}]}]}]},{"type":"SECONDARY","title":"Mean Change From Baseline in Rhinoconjunctivitis Quality-of-Life Score","description":"Patients completed a validated, self-administered questionnaire, which included 28 questions on a 7-point scale \\[score 0 (best) to 6 (worst)\\] across 7 domains: activities, sleep, non-nose/eye symptoms, practical problems, nasal symptoms, eye symptoms, and emotional. The scores for each domain were averaged, then the scores for the 7 domains were averaged for the overall score.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.75","spread":null},{"groupId":"OG001","value":"-0.85","spread":null},{"groupId":"OG002","value":"-0.97","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":333},"commonTop":["Headache"]}}}